Open Access

Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?

Sebastian Blaj

Sebastian Blaj

Klinik für Allgemein- und Viszeralchirurgie, Krankenhaus Barmherzige Brüder RegensburgRegensburg, Germany
Search for this author on
Sciendo|Google Scholar
Blaj, Sebastian
 and 
Pompiliu Piso

Pompiliu Piso

Klinik für Allgemein- und Viszeralchirurgie, Krankenhaus Barmherzige Brüder RegensburgRegensburg, Germany
Search for this author on
Sciendo|Google Scholar
Piso, Pompiliu
  
Mar 09, 2018
Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?'s Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Mar 09, 2018
Page range: 207 - 210
Received: Dec 18, 2017
Accepted: Dec 29, 2017
DOI: https://doi.org/10.1515/cipms-2017-0040
Keywords
© 2017 Sebastian Blaj et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy, Pharmacy, other
Journal RSS Feed